Lusvertikimab selectively inhibits IL-7 but not the thymic stromal lymphopoietin (TSLP) axis, Bourreille told attendees. A ...

The Halton-Peel Gutsy Walk Sunday, June 1 will help raise funds to find a cure for Crohn’s disease and ulcerative colitis.

Molecular-guided decision-making improves disease control and remission in the treatment of IBD with anti-TNF therapy, ...

Discover a study that has revealed a new potential mechanism of understanding inflammation in ulcerative colitis.

A sour, tangy type of cherry that's previously been thought of as only good for baking has become the surprise breakout hit ...

New long-term extension data from the Phase IIb/III QUASAR trial demonstrate that Tremfya (guselkumab) maintains durable ...

Microbiotica unveils multiple mechanisms by which MB310, in clinical development for the treatment of ulcerative colitis, protects the intestinal barrierData presented at Digestive Disease Week in San ...

CHARLOTTE, N.C. -- Wide receiver Hunter Renfrow dropped from 185 pounds to 150 pounds last year while being treated for ...

Johnson & Johnson (NYSE: JNJ) today announced new data from the TREMFYA® (guselkumab) Phase 3 QUASAR long-term extension (LTE) study in adults with moderately-to-severely active ulcerative colitis (UC ...

Proctitis causes rectal discomfort and bleeding. Learn what triggers it, how it's diagnosed, and which treatments actually ...